SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-327488
Filing Date
2014-08-29
Accepted
2014-08-29 16:36:09
Documents
4
Period of Report
2014-08-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d778671d8k.htm 8-K 16654
2 EX-10.37 d778671dex1037.htm EX-10.37 116025
3 EX-10.38 d778671dex1038.htm EX-10.38 48383
4 EX-10.39 d778671dex1039.htm EX-10.39 43866
  Complete submission text file 0001193125-14-327488.txt   226114
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 141075667
SIC: 2834 Pharmaceutical Preparations